1
Yashwant M Deo, Joel Goldstein, Robert Graziano, Chezian Somasundaram: Therapeutic compounds comprised of anti-Fc receptor antibodies. Medarex, Lahive & Cockfield, November 17, 1998: US05837243 (137 worldwide citation)

Multispecific multivalent molecules which are specific to an Fc receptor (FcR), and therapeutic uses and therapeutic uses and methods for making the molecules are described.


2

3
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies. Medarex, Darby & Darby, January 10, 2006: US06984720 (70 worldwide citation)

The present invention provides human sequence antibodies against CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


4
Yashwant M Deo, Joel Goldstein, Robert Graziano, Chezian Somasundaram: Therapeutic compounds comprised of anti-Fc receptor antibodies. Medarex, Jane E Remillard, Peter W Dini, Lahive & Cockfield, August 7, 2001: US06270765 (70 worldwide citation)

Multispecific multivalent molecules which are specific to an Fc receptor (FcR), and therapeutic uses and therapeutic uses and methods for making the molecules are described.


5
Yashwant M Deo, Joel Goldstein, Robert Graziano, Chezian Somasundaram: Therapeutic compounds comprised of anti-Fc receptor antibodies. Mederex, Jane E Remillard, Peter W Dini, Lahive & Cockfield, May 28, 2002: US06395272 (49 worldwide citation)

Multispecific multivalent molecules which are specific to an Fc receptor (FcR), and therapeutic uses and therapeutic uses and methods for making the molecules are described.


6
Yashwant M Deo, Joel Goldstein, Robert Graziano, Tibor Keler: Therapeutic compounds comprised of anti-FC receptor binding agents. Medarex, Jane E Remillard, Peter W Dini, Lahive & Cockfield, April 2, 2002: US06365161 (42 worldwide citation)

Multispecific molecules which target immune cells are disclosed. The molecules are “multispecific” because they bind to multiple (two or more), distinct targets, one of which is a molecule on the surface of an immune cell. Multispecific molecules of the invention include molecules comprised of at le ...


7

8
Yashwant M Deo, Joel Goldstein, Robert Graziano, Chezian Somasundaram: Therapeutic compounds comprised of anti-Fc receptor antibodies. Medarex, Jane E Remillard, Peter W Dini, Lahive & Cockfield, June 25, 2002: US06410690 (21 worldwide citation)

Multispecific multivalent molecules which are specific to an Fc receptor (FcR), and therapeutic uses and therapeutic uses and methods for making the molecules are described.


9
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts, October 20, 2009: US07605238 (16 worldwide citation)

The present invention provides human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


10
Tibor Keler, Joel Goldstein, Robert Graziano, Yashwant M Deo: Cells expressing anti-Fc receptor binding components. Medarex, Giulio A DeConti Jr Esq, Jane E Remillard Esq, Lahive & Cockfield, January 27, 2004: US06682928 (16 worldwide citation)

Cells transformed to express on their surface a component which binds to an Fc receptor of an effector cell are disclosed. Also disclosed are expression vectors used to transform the cells. Once transformed, the cells bind to effector cells via the Fc receptor of the effector cell to stimulate an ef ...